Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

3.38USD
18 Apr 2019
Change (% chg)

$0.02 (+0.60%)
Prev Close
$3.36
Open
$3.35
Day's High
$3.38
Day's Low
$3.31
Volume
176,397
Avg. Vol
361,809
52-wk High
$5.05
52-wk Low
$2.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.61 -0.177
Sep '18 0.38 -0.208
Jun '18 0.82 -0.203
Mar '18 0.34 -0.228
FY 2017 Dec '17 0.74 0.480
Sep '17 1.49 -0.281
Jun '17 2.66 -0.288
Mar '17 3.11 -0.343
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 7 1.79 3.50 0.70 --
Quarter Ending Sep-19 7 2.28 3.70 1.16 --
Year Ending Dec-19 8 7.81 13.40 5.40 25.41
Year Ending Dec-20 8 32.86 47.20 24.92 57.34
Earnings (per share)
Quarter Ending Jun-19 7 -0.22 -0.20 -0.24 --
Quarter Ending Sep-19 7 -0.23 -0.21 -0.26 --
Year Ending Dec-19 7 -0.91 -0.84 -1.01 -0.87
Year Ending Dec-20 7 -0.68 -0.51 -0.93 -0.48
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.30 32.55
P/E High - Last 5 Yrs. -- 147.69 48.10
P/E Low - Last 5 Yrs. -- 47.94 23.42
Beta 3.03 1.08 0.87
Price to Sales (TTM) 14.87 49.51 8.39
Price to Book (MRQ) -- 10.13 5.27
Price to Tangible Book (MRQ) -- 13.74 6.74
Price to Cash Flow (TTM) -- 56.17 24.13
% Owned Institutions 39.70 3.71 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.02 39.61

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.32 206.06 13.46
Sales (TTM) vs TTM 1 Yr. Ago -37.00 49.01 8.04
Sales - 5 Yr. Growth Rate 74.52 22.77 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -17.56 75.31 47.73
EPS (TTM) vs TTM 1 Yr. Ago -79.25 -- --
EPS - 5 Yr. Growth Rate -- 11.97 10.46
Capital Spending - 5 Yr. Growth Rate 13.00 9.11 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.81 2.24 2.18
Current Ratio (MRQ) 4.92 3.57 2.98
LT Debt to Equity (MRQ) -- 18.63 11.32
Total Debt to Equity (MRQ) -- 31.30 16.01
Interest Coverage (TTM) -1.82 -43.11 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 13.88 56.28 52.41
Gross Margin - 5 Yr. Avg. -- 60.50 50.39
EBITD Margin (TTM) -225.81 -- --
EBITD - 5 Yr. Avg -161.51 -110.67 12.41
Operating Margin (TTM) -238.47 -184.95 5.77
Operating Margin - 5 Yr. Avg. -170.81 -127.15 8.01
Pre-Tax Margin (TTM) -319.40 -175.66 4.79
Pre-Tax Margin - 5 Yr. Avg. -212.89 -132.95 8.29
Net Profit Margin (TTM) -319.19 -182.38 1.52
Net Profit Margin - 5 Yr. Avg. -213.88 -137.34 4.70
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 399,205 7,653,551 820,413,093
Net Income/Employee (TTM) -1,274,205 513,615 92,866,243
Receivable Turnover (TTM) 4.98 6.28 5.82
Inventory Turnover (TTM) 9.22 1.89 3.41
Asset Turnover (TTM) 0.16 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -51.83 6.38 10.60
Return on Assets - 5 Yr. Avg. -34.34 5.47 11.78
Return on Investment (TTM) -63.23 8.91 13.83
Return on Investment - 5 Yr. Avg. -39.19 6.79 15.32
Return on Equity (TTM) -- 10.06 15.25
Return on Equity - 5 Yr. Avg. -81.78 8.32 16.41
  1 Year 3 Year 5 Year
Sales % -9.89 -16.21 74.52
EPS (TTM) % -72.93 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AcelRx Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 54.55 49.22 95 99
13 Week 142.86 131.03 98 95
26 Week 85.45 71.36 90 97
52 Week 35.64 14.96 72 69
YTD 96.15 72.26 86 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 19.77%
# of Holders: 82
Total Shares Held: 15,568,291
3 Mo. Net Change: 59,887
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 0
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.